Wall Street Analysts See a 71.97% Upside in Rigel (RIGL): Can the Stock Really Move This High?

Rigel Pharmaceuticals (RIGL) closed the last trading session at $19.62, gaining 0.3% over the past four weeks, but there could be plenty of upside left in the stock if short-term price targets set by Wall Street analysts are any guide. The mean price target of$ 33.74 indicates a 72% upside potential.The mean estimate comprises six short-term price targets with a standard deviation of $17.29. While the lowest estimate of$ 20.45 indicates a 4.2% increase from the current price level, the most optimistic analy ...